07:58:26 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-29 Kvartalsrapport 2024-Q3
2024-08-30 Kvartalsrapport 2024-Q2
2024-05-31 Kvartalsrapport 2024-Q1
2024-05-29 Ordinarie utdelning POLAR 0.00 SEK
2024-05-28 Årsstämma 2024
2024-02-23 Bokslutskommuniké 2023
2023-11-24 Kvartalsrapport 2023-Q3
2023-09-08 Extra Bolagsstämma 2023
2023-08-25 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-17 Årsstämma 2023
2023-05-05 Ordinarie utdelning POLAR 0.00 SEK
2023-03-13 Extra Bolagsstämma 2022
2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2024-04-24 08:46:00

The BBC has spotlighted PolarCool's collaboration with the United Rugby Championship (URC), featuring the med-tech company and its product, PolarCap®. This exclusive coverage reached an expected audience of 8 million viewers live across the BBC yesterday (Tuesday 23[rd] April), on BBC News, BBC Sport, and BBC 5live radio, alongside an online article on BBC.com.

PolarCap® is designed to alleviate the effects of concussions, and is used by sports teams, organizations, and facilities in ice hockey, rugby, football, and handball, as well as other sports which experience a higher risk of concussions.

The BBC coverage highlights the introduction of PolarCap® into the United Rugby Championship this season. This milestone stems from PolarCool's collaboration announcement with the URC in December 2023. As part of the collaboration, PolarCap® has been introduced into the league, across all five countries, this season. In total six URC teams will provide the treatment to their concussed players, marking a significant step forward in professional rugby for PolarCool.

Journalist Felicity Kvesic led the BBC exclusive coverage, filmed at Murrayfield Stadium, the home of Scottish Rugby and professional rugby team Edinburgh Rugby. The coverage included an interview with Dr. Michael Dunlop, URC's Medical Advisor and Edinburgh Team Doctor. Dr. Dunlop provided insight into the scientific underpinnings and the rationale behind introducing PolarCap® into the league:

-The metabolic dysfunction that happens in a concussion is worse if the body's temperature is higher. What that then translates into is hot concussions; sports-related concussions are potentially worse than cold concussions. This product appears to be beneficial in the translated effect of reducing those prolonged stand-down periods players can suffer mainly because they continue to be symptomatic.

The coverage also included an interview with Scotland and Edinburgh Rugby Player Mark Bennett, who has been treated with PolarCap®. Bennett shared his firsthand positive experiences with the treatment:

-From a players' point of view, if there is any suggestion it is going to help us, then absolutely we're going to use it.

Additionally, PolarCool CEO Erik Andersson shared his perspectives on the collaboration:

-I see the different parts of the concussion issue. I think we should focus on all parts and how we can prevent them from happening. How can we have a safe return to play, which is very important, and can we treat it in the acute phase? Well, actually, as of right now, you can.

The coverage comes at a crucial time for rugby, as the sport deals with significant challenges related to concussions. Former professional player groups are currently in litigation against rugby's governing bodies for alleged mishandling of concussions and the long-term symptoms that persist for them. This legal action highlights the seriousness of the issue and the need for continued improvements in concussion management.